Involvement of proapoptotic Bcl-2 family members in terbinafine-induced mitochondrial dysfunction and apoptosis in HL60 cells.

[1]  B. Fang,et al.  Mechanisms of resistance to TRAIL-induced apoptosis in cancer , 2005, Cancer Gene Therapy.

[2]  M. Beauchemin,et al.  Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor-related apoptosis-inducing ligand-mediated cell death. , 2004, Molecular cancer therapeutics.

[3]  C. Rhee,et al.  Arsenic trioxide sensitizes CD95/Fas‐induced apoptosis through ROS‐mediated upregulation of CD95/Fas by NF‐κB activation , 2004, International journal of cancer.

[4]  J. Liu,et al.  Apoptosome dysfunction in human cancer , 2004, Apoptosis.

[5]  D. Hua,et al.  Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling , 2004, Anti-cancer drugs.

[6]  C. Chen,et al.  Inhibition of human vascular endothelial cells proliferation by terbinafine , 2004, International journal of cancer.

[7]  S. Canevari,et al.  CD95-Mediated Apoptosis Is Impaired at Receptor Level by Cellular FLICE-Inhibitory Protein (Long Form) in Wild-Type p53 Human Ovarian Carcinoma , 2004, Clinical Cancer Research.

[8]  J. Nguyen,et al.  Apo cytochrome c inhibits caspases by preventing apoptosome formation. , 2004, Biochemical and biophysical research communications.

[9]  V. Bertagnolo,et al.  Ornithine decarboxylase, polyamines and CD11b expression in HL-60 cells during differentiation induced by retinoic acid. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  U. Testa,et al.  Apoptotic mechanisms in the control of erythropoiesis , 2004, Leukemia.

[11]  T. Kuijpers,et al.  Bid Truncation, Bid/Bax Targeting to the Mitochondria, and Caspase Activation Associated with Neutrophil Apoptosis Are Inhibited by Granulocyte Colony-Stimulating Factor , 2004, The Journal of Immunology.

[12]  E. Solary,et al.  Cisplatin-Induced CD95 Redistribution into Membrane Lipid Rafts of HT29 Human Colon Cancer Cells , 2004, Cancer Research.

[13]  S. Frank,et al.  Bax translocation and mitochondrial fragmentation induced by Helicobacter pylori , 2004, Gut.

[14]  D. Hess,et al.  Minocycline Up-regulates Bcl-2 and Protects against Cell Death in Mitochondria* , 2004, Journal of Biological Chemistry.

[15]  P. Vandenabeele,et al.  Toxic proteins released from mitochondria in cell death , 2004, Oncogene.

[16]  A. Sartorelli,et al.  Combination of all-trans retinoic acid and lithium chloride surmounts a retinoid differentiation block induced by expression of Scl and Rbtn2 transcription factors in myeloid leukemia cells. , 2004, Leukemia research.

[17]  S. Srinivasula,et al.  Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis , 2004, Cell Death and Differentiation.

[18]  Jen-kun Lin,et al.  In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53‐associated cell cycle arrest , 2003, International journal of cancer.

[19]  Y. Ho,et al.  Lipid peroxidation and cell death mechanisms in rats and human cells induced by chloral hydrate. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  R. Medema,et al.  Prevention of B cell antigen receptor-induced apoptosis by ligation of CD40 occurs downstream of cell cycle regulation. , 2002, International immunology.

[21]  Jen-kun Lin,et al.  Microtubule damaging agents induce apoptosis in HL 60 cells and G2/M cell cycle arrest in HT 29 cells. , 2002, Toxicology.

[22]  Yigong Shi,et al.  Mechanisms of caspase activation and inhibition during apoptosis. , 2002, Molecular cell.

[23]  Y. Ho,et al.  Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells , 2001, Molecular carcinogenesis.

[24]  D. Seol,et al.  The role of caspase-8 in resistance to cancer chemotherapy. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[25]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[26]  Y. Wang,et al.  Ketoconazole induces G0/G1 arrest in human colorectal and hepatocellular carcinoma cell lines. , 2000, Toxicology and applied pharmacology.

[27]  D. E. Olins,et al.  Retinoic acid differentiation of HL-60 cells promotes cytoskeletal polarization. , 2000, Experimental cell research.

[28]  S. Srinivasula,et al.  Cytochrome c and dATP-mediated Oligomerization of Apaf-1 Is a Prerequisite for Procaspase-9 Activation* , 1999, The Journal of Biological Chemistry.

[29]  Emad S. Alnemri,et al.  Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1 , 1999, Nature.

[30]  Jen-kun Lin,et al.  Ketoconazole-induced apoptosis through P53-dependent pathway in human colorectal and hepatocellular carcinoma cell lines. , 1998, Toxicology and applied pharmacology.

[31]  J C Reed,et al.  Pro-caspase-3 Is a Major Physiologic Target of Caspase-8* , 1998, The Journal of Biological Chemistry.

[32]  M. Rademaker,et al.  Griseofulvin and terbinafine in the treatment of tinea capitis in children. , 1998, The New Zealand medical journal.

[33]  N. Shear,et al.  Terbinafine: an update. , 1997, Journal of the American Academy of Dermatology.

[34]  John Calvin Reed,et al.  Cytochrome c: Can't Live with It—Can't Live without It , 1997, Cell.

[35]  M. Nahata,et al.  Oral Terbinafine: A New Antifungal Agent , 1997, The Annals of pharmacotherapy.

[36]  Jen-kun Lin,et al.  Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells , 1996, Molecular carcinogenesis.

[37]  J. Kovarik,et al.  Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites , 1995, Antimicrobial agents and chemotherapy.

[38]  S. Kirkesseli,et al.  Pharmacokinetics of terbinafine and of its five main metabolites in plasma and urine, following a single oral dose in healthy subjects , 1995, Biopharmaceutics & drug disposition.

[39]  J. Kovarik,et al.  Dose‐proportional pharmacokinetics of terbinafine and its N‐demethylated metabolite in healthy volunteers , 1992, The British journal of dermatology.

[40]  T G Cotter,et al.  HL‐60 cells induced to differentiate towards neutrophils subsequently die via apoptosis , 1990, Clinical and experimental immunology.

[41]  J. Jensen,et al.  Clinical pharmacokinetics of terbinafine (Lamisil) , 1989, Clinical and experimental dermatology.

[42]  N S Ryder,et al.  Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. , 1984, Science.

[43]  L. Salmena,et al.  CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8 , 2005, Cell Death and Differentiation.

[44]  Ji-Youn Han,et al.  Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer , 2003, Medical oncology.

[45]  C. Borner.  The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. , 2003, Molecular immunology.

[46]  Y. Ho,et al.  Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. , 2000, International journal of cancer.

[47]  R. Ballona,et al.  Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. , 2000, Journal of the American Academy of Dermatology.